KRASmutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: Implication for combinatorial approach
Author:
Publisher
Wiley
Subject
Cancer Research,Molecular Biology
Reference41 articles.
1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005
2. A risk model for prediction of lung cancer;Spitz;J Natl Cancer Inst,2007
3. EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib;Pao;Proc Natl Acad Sci USA,2004
4. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004
5. EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy;Paez;Science,2004
Cited by 115 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A single cell RNAseq benchmark experiment embedding “controlled” cancer heterogeneity;Scientific Data;2024-02-02
2. Targeting Stem Cells and Dysplastic Features With Dual MEK/ERK and STAT3 Suppression in Gastric Carcinogenesis;Gastroenterology;2024-01
3. Response of PRIMPOL-Knockout Human Lung Adenocarcinoma A549 Cells to Genotoxic Stress;Biochemistry (Moscow);2023-11
4. A phase I/IB trial of binimetinib in combination with erlotinib in NSCLC harboring activating KRAS or EGFR mutations;Lung Cancer;2023-09
5. Multi-signal amplification electrochemiluminescence biosensor based on GO-CDTPA-AuNPs composites and PET-RAFT for ultrasensitive detection of KRAS G12C mutation;Microchemical Journal;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3